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ach year in the United States 
alone, more than 200,000 cases 
of breast cancer are diagnosed. 
Most women fi  nd their tumors on their 
own, by feeling a lump in their breast. 
Tumors can be detected in this way be-
cause they are stiffer than normal tissue, 
explains Valerie Weaver, Director of 
UCSF’s Center for Bioengineering and 
Tissue Regeneration. This stiffness is 
both a consequence and a cause of cancer-
ous processes in solid tumors.
Weaver’s work on cancer cells’ interac-
tions with the tumor microenvironment 
had its origins in her postdoctoral work 
with Mina Bissell at UC Berkeley, where 
she studied how integrin signaling affects 
the phenotypes of tumor cells (1, 2). Now, 
she is at the forefront of a burgeoning new 
fi  eld, mechanotransduction, which seeks a 
better understanding of how cells sense 
and respond to physical forces (3–5). 
When discussing her career, she says it 
hasn’t always been easy getting to that posi-
tion, but, even with all the challenges she’s 
faced, it’s been worth it.
RIGHT CHOICE
When did you decide on 
a career in science?
I come from a working-
class background. Growing 
up, none of my friends were 
university bound. I think it was expected 
that I should learn how to type and get 
some kind of job with a nice pension, then 
get married and have a family. But I think 
I always knew I wanted something differ-
ent for myself. I was a huge reader—I love 
books—and maybe that was why I decid-
ed to go to university. But I don’t think I 
seriously considered a science career until 
well after that.
After college, I was working at Chalk 
River Nuclear Labs, and my supervisor 
there really encouraged me to try to go 
farther. She could see my potential even 
though I couldn’t. So I went to graduate 
school at the University of Ottawa and 
started a postdoc at the Canadian Re-
search Council. My horizons just opened 
up—there were so many possibilities. But 
I still didn’t really know if I could or 
should pursue a research career.
Then I saw Mina Bissell give a presen-
tation at the Canadian Federation of Bio-
logical Sciences meeting in Windsor. I 
somehow worked up the guts to run up to 
her at the end of the meeting and say, “Oh, 
I’d love to do a postdoc with you.” To my 
surprise, she said, “Well, contact me.”
So off you went to your postdoc?
Actually, no, not right away. I’d had a 
rough time during graduate school—my 
father died from a brain tumor, and I was 
in a really horrific car accident. And I 
wondered: do I have what it takes? Can I 
really do this? I needed time to think it 
through, so I just… took off.
I never told Mina my plans. I used the 
settlement money from my car accident 
and bought a plane ticket to Africa. I 
spent six months traveling around, end-
ing up in India. It was an 
amazing experience, but, 
along the way, I had this 
revelation: I realized that I 
was really lucky that I had 
the opportunity to get an 
education and do reason-
ably well for myself in life. 
I had a certain capacity for doing research, 
and I had a passion for doing it.
I ended up phoning Mina from a 
phone booth in Kathmandu and telling 
her that I wanted to come start my post-
doc with her. It was a great choice: Mina 
is another person who really believed in 
me. Her belief gave me the power to 
think bigger and to expand my vision, to 
see where I needed to go.
RIGHT REASONS
And you never looked back?
I’ve met several students who seem con-
fused about why they are pursuing a re-
search career. They have all these external 
expectations put on them, and they put so 
much stock in whether they get a particu-
lar award or grade, as opposed to whether 
this is what they really want to do. I didn’t 
have any expectations placed on me, so 
it was easier for me to decide that I was 
doing it for the right reasons.
As I tell my students, science is a tough 
job, but it’s important to realize that no-
body owes us this. We’re lucky to do this! 
It’s challenging and fun and interesting… 
I celebrate science and what it offers; 
hopefully that’ll help draw people in for 
the right reasons.
What interests did you pursue in your 
postdoc?
Mina had recently published some papers 
with Nancy Boudreau where they showed 
that normal breast epithelial cells in 3D 
culture apoptose when they lose cell adhe-
sion, but tumor cells are resistant to this 
kind of death. I wanted to look at how that 
pathway is altered in tumors and how tu-
mors become resistant to apoptosis. So, 
after consulting Mina, I contacted Ole 
Petersen’s group in Copenhagen, which 
had a bunch of human cell lines at differ-
ent stages of tumor progression, and started 
trying to find out at what point during 
tumorigenesis they could no longer be 
killed by blocking cell adhesion.
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Weaver investigates the mechanical properties of tumors and how 
changes in the tumor microenvironment influence cancer cell behavior.
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“I celebrate 
science 
and what it 
offers.”
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The really early lines died like crazy 
when you blocked 1 integrin, and, as the 
disease progressed, they died less, as ex-
pected. But when I got to fully progressed 
tumors, I remember looking at the cul-
tures and thinking, “Okay, I must have 
mixed these up because they look just like 
normal cells.” What was happening was 
that, by blocking 1 integrin, we were 
sending the tumor cells into phenotypic 
reversion; they were no longer invasive. 
This showed that signals from the envi-
ronment are important for driving tumor 
cells’ behavior.
RIGHT ENVIRONMENT
That’s the subject you’ve chosen to 
pursue in your own lab?
I was hired at UPenn as part 
of what was going to be a 
big interdisciplinary cancer 
research group. But shortly 
after I got there the Univer-
sity had a funding crisis and 
stopped hiring. It ended up 
that I was the only cancer 
researcher in what was really 
an engineering and physics 
group. I couldn’t get gradu-
ate students to come over because they 
were terrifi  ed by all the physics and engi-
neering, and the lab was way on the other 
side of campus from the biological sciences 
labs. So I hired a technician, Nastaran 
Zahir, and trained her in lab work, hoping 
that she might stay to do grad school—
and she did.
I was trying to think of a project for 
Nas that was relevant to my interests and 
to engineering. To make a long story 
short, I started wondering about things 
like viscoelasticity and whether that 
might impact tumor behavior in a 3D 
environment. We started thinking about 
when the mammary acinus expands dur-
ing development or during tumor pro-
gression. Could there be some kind of 
physical force that’s altered, and could 
we model it?
But I couldn’t get any money for 
these studies. No one would take a 
chance on a grant for this; it just sounded 
too crazy. We ended up going around, 
collecting other peoples’ extra mice—
mice with myc- or ras-based tumors or 
whatever—to see if we could make 
force measurements on 
them. And what we found 
was that breast tumors are 
stiffer than normal tissue. 
We’ve been expanding on 
that ever since.
How does stiffness in the 
tumor environment impact 
cancer cells’ behavior?
Think of it this way. Mam-
mals start off as one little 
egg, which is very soft and is not under 
tension. As an animal develops differ-
ent tissue types, these different tissues 
have different properties of stiffness or 
softness, and the cells in them tune 
themselves to the stiffness of the extra-
cellular matrix in their environment. 
They do this, in part, through ion channel 
activation but also through clustering 
of integrins. This changes the activation 
of Rho GTPases, which in turn al-
ters actomyosin contractility and 
actin behavior. That then feeds 
back and changes how receptors 
function (by affecting their clus-
tering or localization), which then 
drives reorientation of matrix bun-
dles and more deposition, stiffen-
ing the local environment. You can 
therefore drive different confi  gu-
rations of cell surface receptors—
literally reprogram the cell—sim-
ply by changing the stiffness of 
the cell’s environment.
When you talk about a breast tumor, or 
other tumors we work on like pancreatic 
or brain tumors, they don’t have to stiffen 
very much to become a tumor. Tumor 
cells are hypersensitive to stiffness changes 
because many oncogenes change the cell’s 
actomyosin contractility. We’re also fi  nd-
ing that oncogenes change things like the 
glycocalyx and cell surface glycoproteins, 
which can also affect the cell’s mechan-
ical characteristics. We can actually use 
atomic force microscopy and fl  uorescence 
image contrast (FLIC) microscopy to 
measure some of these changes.
I’m excited about how things are turn-
ing out. I love where our work is going, 
and I think people are fi  nally starting to 
pick up on how interesting this stuff is. Of 
course, we have a long way to go. But I 
have a nice group and I feel extremely 
privileged to be part of this.
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A 3D reconstruction showing how membrane 
surface topology changes in cancerous cells.
“Signals 
from the 
environment 
are important 
for driving 
tumor cells’ 
behavior.”
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Weaver and graduate student Yekaterina Miroshnikova 
discuss new data.